Commentary Factor VII and the brain: time to get this research done!University of Maryland School of Medicine, R Adams Cowley Shock Trauma Center, University of Maryland Medical System, MA, USA
Critical Care 2007, 11:161doi:10.1186/cc6097
See related research by Kluger et al., http://ccforum.com/content/11/4/R85 AbstractTraumatic brain injury is the leading killer after trauma, in part because of coagulopathy. Factor VIIa may be a useful therapy in this setting, depending on the relative risk for thromboembolic complications. Kluger and coworkers recently conducted a retrospective review of patients with traumatic brain injury from a previous factor VIIa and trauma trial. It documents an encouragingly low rate of complications, and should provide a strong incentive to conduct a prospective study of factor VIIa in patients with severe traumatic brain injury. |




on Google Scholar







author email
corresponding author email